94 related articles for article (PubMed ID: 16711)
21. Influence of the timing of blood transfusion on experimental tumor growth.
Francis DM; Clunie GJ
J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
Mizushima Y; Sendo F; Takeichi N; Hosohawa M; Kobayashi H
Cancer Res; 1981 Jul; 41(7):2917-21. PubMed ID: 6454480
[TBL] [Abstract][Full Text] [Related]
23. Prevention of tumors in rats by cross-protective immunization.
Fish DC; Bare AL; Djurickovic DB; Huebner RJ
J Natl Cancer Inst; 1981 Nov; 67(5):1041-51. PubMed ID: 6946246
[TBL] [Abstract][Full Text] [Related]
24. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
25. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
[TBL] [Abstract][Full Text] [Related]
26. Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation.
Oluwole SF; Iga C; Lau H; Hardy MA
J Heart Transplant; 1985; 4(4):385-9. PubMed ID: 2956395
[TBL] [Abstract][Full Text] [Related]
27. Effect of combination treatment with cyclophosphamide and nonspecific passive immunization on a transplantable tumor in WKA rats.
Gotohda E; Kawamura T; Sendo F; Nakayama M; Akiyama J
Cancer Res; 1976 Jul; 36(7 PT 1):2119-23. PubMed ID: 1277122
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.
Rolstad B; Benestad HB
Immunology; 1991 Sep; 74(1):86-93. PubMed ID: 1937576
[TBL] [Abstract][Full Text] [Related]
29. The transfusion effect is influenced by the nature of MHC antigen presentation.
Grindel SI; Wiederkehr JC; Pollak R
Curr Surg; 1990; 47(5):321-6. PubMed ID: 2257746
[TBL] [Abstract][Full Text] [Related]
30. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
31. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
[TBL] [Abstract][Full Text] [Related]
32. An experimental assessment of the effect of blood transfusion on susceptibility to bacterial infection.
Galandiuk S; George CD; Pietsch JD; Byck DC; DeWeese RC; Polk HC
Surgery; 1990 Sep; 108(3):567-71. PubMed ID: 2396200
[TBL] [Abstract][Full Text] [Related]
33. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
34. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
35. The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats.
Mizushima Y; Koga Y; Yuhki N; Kobayashi H
Gan; 1983 Feb; 74(1):162-8. PubMed ID: 6840435
[TBL] [Abstract][Full Text] [Related]
36. The significance of free blood in liquid and solid tumours.
Van den Brenk HA; Crowe M; Kelly H; Stone MG
Br J Exp Pathol; 1977 Apr; 58(2):147-59. PubMed ID: 861165
[TBL] [Abstract][Full Text] [Related]
37. Enhanced growth of artificial tumor metastases following blood transfusion: the effect of erythrocytes, leukocytes and plasma transfusion.
Singh SK; Marquet RL; Westbroek DL; Jeekel J
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1537-40. PubMed ID: 3678317
[TBL] [Abstract][Full Text] [Related]
38. Effect of allogeneic blood transfusions on the growth of two different tumours in the rat.
Rössler W; Dreikorn K; Lenhard V; Zeller WJ; Scholler P
Urol Int; 1985; 40(4):217-9. PubMed ID: 4049579
[TBL] [Abstract][Full Text] [Related]
39. Modulation of tumor growth by allogeneic blood transfusion.
Marquet RL; de Bruin RW; Dallinga RJ; Singh SK; Jeekel J
J Cancer Res Clin Oncol; 1986; 111(1):50-3. PubMed ID: 3949850
[TBL] [Abstract][Full Text] [Related]
40. Acceleration of B16 melanoma growth in mice after blood transfusion.
Francis DM; Burren CP; Clunie GJ
Surgery; 1987 Sep; 102(3):485-92. PubMed ID: 3629476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
